A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABAA receptor modulator - an in vitro and in vivo comparison

Development and SAR of functionally selective allosteric modulators of GABAA receptors

(2011) Cristobal Alhambra et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Evaluation of models for predicting drug–drug interactions due to induction

(2010) Odette A Fahmi et al.   Expert Opinion on Drug Metabolism & Toxicology

Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2

(2009) Shu-Feng Zhou et al.   CURRENT DRUG METABOLISM

Evaluation of Multiple in Vitro Systems for Assessment of CYP3A4 Induction in Drug Discovery: Human Hepatocytes, Pregnane X Receptor Reporter Gene, and Fa2N-4 and HepaRG Cells

(2009) D. F. McGinnity et al.   DRUG METABOLISM AND DISPOSITION

In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective

(2009) V. Chu et al.   DRUG METABOLISM AND DISPOSITION

Subtype-selective GABAA receptor mimetics—novel antihyperalgesic agents?

(2009) Hanns Ulrich Zeilhofer et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping

(2008) Bettina Link et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

(2008) K. P. Kanebratt et al.   DRUG METABOLISM AND DISPOSITION